Left ventricular hypertrophy (LVH) is the most frequent cardiac abnormality in patients with end-stage renal disease (ESRD).
Introduction
The cardiovascular mortality rate is higher in hemodialysis patients than in the non-uremic population. In a previous epidemiological study, damage to large arteries was shown to be a major factor contributing to the high cardiovascular morbidity and mortality of patients with end-stage renal disease (ESRD) (1) . Previous clinical studies (2, 3) have found that sclerosis of the abdominal aorta reflects early atherosclerosis and is significantly correlated with coronary arteriosclerosis. Arteriosclerosis involves two important changes: thickening and stiffening of the arterial wall (4) . The increased stiffness raises systolic blood pressure (BP) and pulse pressure while decreasing diastolic BP, thereby causing increased left ventricular afterload and altered coronary perfusion. Thus, increased arterial stiffness may be associated with left ventricular hypertrophy (LVH) in patients with ESRD.
It has been reported that patients with ESRD have stiffer arteries than age-and BP-matched non-uremic subjects (5) . Moreover, arterial hypertrophy is accompanied by an incremental increase in elastic modulus value and a large increase in pulse-wave velocity (PWV) in these patients (6, 7) . Recently, Blacher et al. (8) reported that aortic stiffness predicts all-cause and cardiovascular mortality in patients with ESRD, suggesting that arterial wall stiffness may be a good predictor of cardiovascular mortality in ESRD patients. In hemodialysis patients, aortic PWV was found to be associated with mediacalcinosis of the aorta and an elevation of calcium phosphate (Ca P) (6, 9) . However, the relationship among LVH, arterial stiffness, and vascular calcification has not been fully elucidated.
The purpose of the present study was to evaluate the contribution of arterial stiffness and arterial calcification to LVH in hemodialysis patients.
Methods

Patient and Study Design
The study subjects were 49 (27 men and 22 women) maintenance haemodialysis patients enrolled in the Dialysis Unit of Minami Senju Hospital. The underlying diseases were type 2 diabetes mellitus (DM) in 17 patients and chronic glomerulonephritis (CGN) without DM in 32. We excluded patients with severe illnesses such as liver cirrhosis and congestive heart failure or apparent acute inflammatory symptoms.
Hemodialysis was performed three times weekly (4 h/day) using hollow-fiber dialyzers such as cellulose triacetate (FB, Nipro, Osaka, Japan) and polysulfone (PS, Fresenius, BadHomburg, Germany). These patients had undergone dialysis for at least six months prior to the study, using the same membrane and the same dialysis procedure for at least three months. Their mean dialysate potassium concentration was 2.0 mEq/l, the mean calcium concentration was 3.0 mEq/l, the mean blood flow rate was 200 ml/min, and the mean dialysate flow rate was 500 ml/min. Residual urine volumes of the hemodialysis patients were less than 100 ml/day. BP was measured with a standard mercury sphygmomanometer and cuffs adapted to arm circumference. BP was recorded after the subjects had been recumbent for at least 10 min.
Blood was drawn in the morning after an overnight fast of at least 12 h before starting a dialysis session. Whole blood was used for measuring hematocrit, EDTA-plasma for measuring fasting plasma glucose and lipids, and serum for the other biochemical assays, including the assay of albumin, which was measured using a commercially available kit (IATRONE Co., Tokyo, Japan). C-reactive protein (CRP) was determined by a latex-aggregation method (IATRONE). Intact parathyroid hormone (iPTH) was measured by radioimmunoassay (normal range: 10-65 pg/ml), as previously described (10) . Other measurements were made by routine methods.
Investigations were performed in the morning before the first weekly dialysis session. Each subject gave informed consent to participate in the study. This study was approved by the ethics committee of our hospital. 13.6. The LVM index (LVMI) was calculated as LVM divided by body surface area. Inter-and intraobserver reproducibilities were less than 5%. Forty (81.6%), 32 (65.3%), and 15 (30.6%) of the 49 patients were given Ca antagonists, angiotensin-converting enzyme inhibitors, and α-blockers, respectively. No patient was given β-blockers.
No drugs were discontinued before the echocardiographic evaluations.
Assessment of Arterial PWV
Occlusion and monitoring cuffs were placed snugly around both sides of the upper and lower extremities, with patients in the supine position. Then, pressure waveforms of the brachial and tibial arteries were recorded after 15 min of bed rest using an automatic waveform analyzer (BP-203RPE; Colin, Komaki, Japan). Electrocardiographic monitoring was performed with electrodes placed on both wrists. Heart sounds, S1 and S2, were detected by a microphone set on the left edge of the sternum at the fourth intercostal space. The pressure waveforms obtained at two different sites were simultaneously recorded to determine the time interval between the initial rise in the brachial and tibial pressure waveforms (∆Ta). The path length from the suprasternal notch to the elbow (∆Da) was obtained from superficial measurements and was expressed using the following equation: ∆Da 0.2195 H 2.0734, where H (in cm) is the height of the patient. The path length from the suprasternal notch to the femur to the ankle (∆Db) was calculated as follows: ∆Db (0.5643 H 18.381) (0.2486 H 30.709). The following equation was used as a surrogate index of PWV in the lower extremities: (∆Db ∆Da)/∆Ta. The best 10 consecutive pulses were analyzed, and the average PWV from the heart to the posterior tibial artery was calculated by dividing the distance by the time interval. Two measurements were performed in each leg and the average value was used for the analysis. PWV was expressed in cm/s. The coefficient of variation of the PWV was less than 5%. This method has been validated in type 2 diabetic patients (14) , patients with coronary artery disease (15) , and patients on chronic dialysis (16) .
Determination of Aortic Calcification Index (ACI) by CT
We performed a prospective longitudinal study using CT scans to detect aortic calcification. As previously described (10, 17) , the abdominal aorta was studied by noncontrast CT scan in consecutive sequential 8-mm slices, and the ACI was estimated as the proportion of aortic circumference covered by calcification. By this method, arteriosclerosis was quantified morphometrically in the cross-section with the most extensive aortosclerosis. The arithmetic mean values of three measurements were calculated and used for analysis. The ACI was independently checked by two observers. Reproducibility was absolute for the patients studied. The sequence of CT scans and their orientation were standardized, and the qualities of scans were primarily dependent on the hardware used. To optimize reproducibility, all scans from the cross-sectional study were done by the same investigator using the same CT equipment as previously described (17) .
Statistical Analysis
All values are expressed as the means SD. Differences between mean values of the two groups were assessed by ANOVA. Pearson's correlation coefficient was used to test the association between two kinds of parameters. To assess the combined influence of variables on PWV, ACI, and LVMI, we used a stepwise linear regression analysis with forward and backward elimination procedures. Statistical analyses were performed using the Stat View statistical software package (Stat View 5; SAS Institute, Cary, USA). Values of p 0.05 were considered to indicate statistical significance.
Results
Baseline Characteristics in Hemodialysis Patients
Clinical parameters of the hemodialysis patients in the present study are summarized in Table 1 . Their mean age was 60.4 1.6 years, and the mean duration of dialysis therapy was 9.6 0.8 years. Twenty-seven patients (55.1%) were men, and 17 patients (34.7%) had diabetes.
Analysis of Arterial Stiffness
To examine the relationships between arterial stiffness and clinical parameters, univariate analysis was performed. The PWV value correlated positively with age (r 0.438, p 0.0015) and serum triglycerides (r 0.32, p 0.0247), but negatively with serum albumin levels (r 0.435, p 0.0016). To assess the combined influence of variables on arterial PWV, we used a stepwise linear regression analysis. The model included the following variables: age, BP, duration of dialysis, blood lipids, fasting plasma glucose, hematocrit, Ca P product, CRP, and ACI. Three of these factorsage, age, triglyceride, and albumin-were independently associated with PWV values.
Analysis of Vascular Calcification
To examine the relationship between vascular calcification and clinical parameters, univariate analysis was performed. The ACI value correlated positively with age (r 0.421, p 0.0023) and iPTH (r 0.318, p 0.0255). To assess the combined influence of variables on ACI, a stepwise linear regression analysis was performed. The model included the following variables: age, BP, duration of dialysis, blood lipids, fasting plasma glucose, albumin, Ca P product, iPTH, and CRP. Age and iPTH were independently associated with the ACI values.
Assessment of the Factors Related to LVH
As shown in Fig. 1 , LVMI values correlated positively with PWV values (r 0.439, p 0.0014, Fig. 1 ), systolic BP (r 0.421, p 0.0023, Fig. 2 ) and ACI (r 0.467, p 0.0006, Fig. 3) . A stepwise linear regression analysis was performed to adjust for the influences of different pathogenic factors on LVH in all patients. The clinical parameters of age, duration of dialysis, diastolic BP, serum levels of albumin, cholesterol, and triglyceride, and fasting plasma glucose, CRP, C P product, iPTH, and hematocrit were not independently associated with LVH. Stepwise regression analysis indicated that ACI (coefficient β 0.401, p 0.0001), systolic BP (coefficient β 0.345, p 0.0001), and arterial PWV (coefficient β 0.342, p 0.0001) were independently associated with LVH (Table 2) .
Discussion
LVH is the most frequent cardiac abnormality in patients starting ESRD therapy (18) , and is a strong and independent risk factor for cardiovascular morbidity and mortality in these patients (19) . LVH in ESRD patients is principally due to an increased demand in left ventricular minute work resulting from volume/flow and pressure overload (20) . Hypertension is present in approximately 80-90% of ESRD patients and is an important factor in the development of LVH in these patients (21) (22) (23) . The presence of hypertension in ESRD patients implies pressure and/or volume overload. However, a previous study reported discrepancies between BP values and the degree of LVH in dialysis patients (21) . In the present study, systolic BP correlated significantly with LVH in univariate analysis, and systolic BP was a strong contributor to the development of LVH in stepwise linear re- Arterial stiffness increases with age and hypertension (6, 24) . In patients with ESRD, arterial stiffness has been shown to be increased in comparison to age-and BP-matched nonuremic subjects. This increase in arterial stiffness is certainly of multifactorial origin, but the exact mechanisms are not clear. In hemodialysis patients, aortic PWV has been associated with mediacalcosis of the aorta and an elevation in Ca P product (6, 9) . In the present study, a stepwise linear regression analysis revealed that several factors, i.e., age, higher serum triglyceride levels, and lower serum levels of albumin, were significantly associated with PWV in hemodialysis patients. The susceptibility of ESRD patients to oxidative stress might be attributable to increased free radical and reactive oxygen metabolite production and to increased levels of oxidizable substances, especially triglycerides with unsaturated fatty acids (25) . On the other hand, Kaysen (26) reported that serum albumin concentration was inversely proportional to that of either CRP or serum amyloid A protein, suggesting that hypoalbuminemia was primarily a response to inflammation, although malnutrition might also have made a contribution. As a result of hypertension in addition to increased oxidative stress and inflammation, arterial stiffness is apparently altered in hemodialysis patients. The positive correlation between LVMI and PWV in the present study suggests that arterial stiffness may contribute to the development of LVH in these patients. However, PWV was not a significant contributor to LVH in the stepwise linear regression analysis.
Vascular calcification is also strongly associated with an increased risk of cardiovascular events and mortality in uremic patients (27, 28) . As in non-uremic patients, calcification in those with ESRD occurs in the arterial intima in association with atherosclerotic plaques (29) . However, medial calcification can also occur and probably increases arterial stiffness and ventricular afterload (30) . Goodman et al. (31) recently demonstrated a high prevalence of coronary artery calcification among young adults receiving dialysis, especially those who had been on dialysis for more than 10 years. Multiple risk factors have been implicated in the development of arterial calcifications. In previous studies, cardiovascular calcification in patients with ESRD has been variably associated with age, duration of dialysis, race, DM, serum P, Ca, HDL-cholesterol and triglyceride concentrations, and markers of inflammation (28) (29) (30) (31) (32) (33) (34) . However, no consistent and/or constant associations could be established between arterial remodeling and common vascular risk factors. In the present study, several factors, including age and iPTH, were independently associated with ACI. Moreover, ACI was an independent variable contributing to the development of LVH according to stepwise linear regression analysis. Therefore, the extent of vascular calcification may be associated with the progression of LVH in patients with ESRD.
In conclusion, we have shown clearly that LVH is associated with hypertension, increased arterial stiffness, and the extent of vascular calcification in hemodialysis patients, with vascular calcification making the most important contribution to the development of LVH. Alteration of pulsatile dynamics contributes to an increase in left ventricular load and is related to the LVH in these patients.
